Record Q4 Orders Leave Siemens Healthineers Upbeat In COVID-19 Affected Year
Executive Summary
Germany’s largest medtech group forecasts a 5-8% rebound in 2021 after a challenging 2020 saw comparable sales dip by 2% in the fourth quarter.
You may also be interested in...
JPM 2021: Intuitive Surgical, Accelerate Diagnostics, Siemens Healthineers, Exact Sciences, Renalytix
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the third day of the meeting.
Industry Impact: Siemens Healthineers $16.4Bn Acquisition Of Varian – What Next?
Siemens Healthineers' acquisition of radiation oncology company Varian Medical Systems creates an oncology giant. Analysts disagree on whether its the right move for the companies.
GDP And UDI On List Of Regulatory Changes Under Taiwan Medical Device Act
Taiwan’s Medical Device Act was enforced on 1 May, bringing changes to good distribution practice and laying the foundation for UDI regulations.